Elite in Acromegaly

Dr. Pamela Freda

Oncology
CUIMC/Harkness Pavilion
180 Fort Washington Ave Ste 512, 
New York, NY 
Offers Telehealth
Elite in Acromegaly
CUIMC/Harkness Pavilion
180 Fort Washington Ave Ste 512, 
New York, NY 
OverviewInsuranceLocationsClinical Research

Overview

Pamela Freda is an Oncologist in New York, New York. Dr. Freda is rated as an Elite provider by MediFind in the treatment of Acromegaly. Her top areas of expertise are Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, and Pituitary Tumor.

Her clinical research consists of co-authoring 49 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 37 articles and participated in 3 clinical trials in the study of Acromegaly.

Specialties
Oncology
Licenses
Internal Medicine in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Nippon Life
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

CUIMC/Harkness Pavilion
180 Fort Washington Ave Ste 512, New York, NY 10032
Call: 914-505-6511

Additional Areas of Focus

Dr. Freda has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Prospective Study of Outcome After Therapy for Acromegaly
A Prospective Study of Outcome After Therapy for Acromegaly
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Procedure, Drug, Diagnostic test
Treatment Patterns and Treatment Outcomes in a New York City Based Cohort of 520 Patients With Acromegaly
Treatment Patterns and Treatment Outcomes in a New York City Based Cohort of 520 Patients With Acromegaly
Enrollment Status: Completed
Publish Date: May 13, 2025
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Radiation, Procedure
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Enrollment Status: Completed
Publish Date: May 29, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

49 Total Publications

Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.
Journal: Nature reviews. Endocrinology
Published: May 12, 2025
View All 49 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Freda's expertise for a condition
ConditionClose
  • Elite
  • Acromegaloid Facial Appearance Syndrome
    Dr. Freda is
    Elite
    . Learn about Acromegaloid Facial Appearance Syndrome.
    See more Acromegaloid Facial Appearance Syndrome experts
  • Acromegaly
    Dr. Freda is
    Elite
    . Learn about Acromegaly.
    See more Acromegaly experts
  • Hypertrichosis-Acromegaloid Facial Appearance Syndrome
    Dr. Freda is
    Elite
    . Learn about Hypertrichosis-Acromegaloid Facial Appearance Syndrome.
    See more Hypertrichosis-Acromegaloid Facial Appearance Syndrome experts
  • Distinguished
  • Gigantism
    Dr. Freda is
    Distinguished
    . Learn about Gigantism.
    See more Gigantism experts
  • Hypothalamic Tumor
    Dr. Freda is
    Distinguished
    . Learn about Hypothalamic Tumor.
    See more Hypothalamic Tumor experts
  • Pituitary Tumor
    Dr. Freda is
    Distinguished
    . Learn about Pituitary Tumor.
    See more Pituitary Tumor experts
  • Sotos Syndrome
    Dr. Freda is
    Distinguished
    . Learn about Sotos Syndrome.
    See more Sotos Syndrome experts
  • Advanced
  • Cushing's disease
    Dr. Freda is
    Advanced
    . Learn about Cushing's disease.
    See more Cushing's disease experts
  • Cushing's syndrome
    Dr. Freda is
    Advanced
    . Learn about Cushing's syndrome.
    See more Cushing's syndrome experts
  • Growth Hormone Deficiency (GHD)
    Dr. Freda is
    Advanced
    . Learn about Growth Hormone Deficiency (GHD).
    See more Growth Hormone Deficiency (GHD) experts
  • Hypogonadism
    Dr. Freda is
    Advanced
    . Learn about Hypogonadism.
    See more Hypogonadism experts
  • Hypogonadotropic Hypogonadism
    Dr. Freda is
    Advanced
    . Learn about Hypogonadotropic Hypogonadism.
    See more Hypogonadotropic Hypogonadism experts
  • Hypopituitarism
    Dr. Freda is
    Advanced
    . Learn about Hypopituitarism.
    See more Hypopituitarism experts
View All 14 Advanced Conditions
  • Experienced
  • Craniopharyngioma
    Dr. Freda is
    Experienced
    . Learn about Craniopharyngioma.
    See more Craniopharyngioma experts
  • Cushing's syndrome due to Adrenal Tumor
    Dr. Freda is
    Experienced
    . Learn about Cushing's syndrome due to Adrenal Tumor.
    See more Cushing's syndrome due to Adrenal Tumor experts
  • Deafness Hypogonadism Syndrome
    Dr. Freda is
    Experienced
    . Learn about Deafness Hypogonadism Syndrome.
    See more Deafness Hypogonadism Syndrome experts
  • Exogenous Cushing's syndrome
    Dr. Freda is
    Experienced
    . Learn about Exogenous Cushing's syndrome.
    See more Exogenous Cushing's syndrome experts
  • Infertility
    Dr. Freda is
    Experienced
    . Learn about Infertility.
    See more Infertility experts
  • Multiple Endocrine Neoplasia Type 1
    Dr. Freda is
    Experienced
    . Learn about Multiple Endocrine Neoplasia Type 1.
    See more Multiple Endocrine Neoplasia Type 1 experts
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.